Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-10-18 Option Award |
2024-10-21 8:41 pm |
2025-05-31 2034-10-17 |
Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director |
34,000 | $0 | 34,000 (Direct) |
View |
2024-06-06 Option Award |
2024-06-10 4:05 pm |
N/A 2034-06-05 |
Generation Bio Co. | GBIO | Stehman-Breen Catherine Director |
60,000 | $0 | 60,000 (Direct) |
View |
2024-05-22 Option Award |
2024-05-24 5:10 pm |
N/A 2034-05-21 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
25,133 | $0 | 25,133 (Direct) |
View |
2023-06-09 Option Award |
2023-06-12 8:34 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director |
29,532 | $0 | 29,532 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:15 pm |
N/A 2033-06-07 |
Generation Bio Co. | GBIO | Stehman-Breen Catherine Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-05-24 Option Award |
2023-05-25 6:38 pm |
N/A 2033-05-23 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
24,900 | $0 | 24,900 (Direct) |
View |
2022-07-05 Option Award |
2022-07-06 6:23 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
7,222 | $0 | 7,222 (Direct) |
View |
2022-06-10 Option Award |
2022-06-13 8:59 pm |
2023-06-10 2032-06-09 |
Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director |
39,727 | $0 | 39,727 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:05 pm |
N/A 2032-06-08 |
Generation Bio Co. | GBIO | Stehman-Breen Catherine Director |
19,200 | $0 | 19,200 (Direct) |
View |
2022-06-03 Option Award |
2022-06-06 4:09 pm |
N/A 2032-06-02 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
19,596 | $0 | 19,596 (Direct) |
View |
Ownership |
2021-07-29 7:36 pm |
N/A N/A |
Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director |
0 | $0 | 30,000 (Direct) |
View |
2021-06-09 Option Award |
2021-06-11 4:09 pm |
N/A 2031-06-08 |
Generation Bio Co. | GBIO | Stehman-Breen Catherine Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-05-26 Option Award |
2021-05-27 8:43 pm |
N/A 2031-05-25 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
19,596 | $0 | 19,596 (Direct) |
View |
2020-07-31 Option Award |
2020-09-23 7:03 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
25,600 | $0 | 176,887 (Direct) |
View |
2020-09-21 Conversion |
2020-09-23 7:03 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
46,299 | $0 | 176,887 (Direct) |
View |
Ownership |
2020-09-16 8:54 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
0 | $0 | 174,121 (Direct) |
View |
2020-06-16 Conversion |
2020-06-18 5:32 pm |
N/A N/A |
Generation Bio Co. | GBIO | Stehman-Breen Catherine Director |
14,004 | $0 | 47,523 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 5:25 pm |
N/A 2030-06-10 |
Generation Bio Co. | GBIO | Stehman-Breen Catherine Director |
52,000 | $0 | 52,000 (Direct) |
View |
Ownership |
2020-06-11 8:37 pm |
N/A N/A |
Generation Bio Co. | GBIO | Stehman-Breen Catherine Director |
0 | $0 | 47,523 (Direct) |
View |